MiMedx Group (MDXG) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MDXG Hot Sheet
Join SI Premium – FREE
MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of $0.05, $0.02 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $57 million versus the consensus estimate of $56.49 million.
GUIDANCE:
MiMedx Group sees Q3 2016 EPS of $0.21-$0.23, versus the consensus of $0.09. MiMedx Group sees Q3 2016 revenue of $62-64 million, versus the consensus of $63.0 million.
For earnings history and earnings-related data on MiMedx Group (MDXG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- CompX International (CIX) Reports Q3 EPS of $0.44
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
